Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Children's Oncology Group
Mayo Clinic
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
Novartis
Columbia University
Checkpoint Therapeutics, Inc.
Peking University People's Hospital
University Medical Center Groningen
Corvus Pharmaceuticals, Inc.
Blue Note Therapeutics
Incyte Corporation
Hospices Civils de Lyon
GlaxoSmithKline
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
University of Alabama at Birmingham
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Netherlands Open University